Natural raw materials exhibit high variability in active compound concentrations due to harvest timing and extraction inefficiencies. Standardizing these inputs prevents sub-optimal potency and industrial waste.

Biological materials suffer from high mortality and physiological degradation during propagation and long-term storage. Reducing these losses ensures the preservation of genetic integrity and agricultural productivity.

Variability in raw material composition and purification efficiency leads to unpredictable final product efficacy. Standardizing multi-component profiles ensures therapeutic reproducibility and safety.